New diabetes pill enters early human testing
Disease control
Ongoing
This early-stage study tests a new oral medication, ZE63-0302, in 60 adults with type 2 diabetes. The main goal is to check the drug's safety and how the body processes it. Participants must have had diabetes for at least 7 years and be on stable diabetes medicines (excluding ins…
Phase: PHASE1 • Sponsor: Eilean Therapeutics • Aim: Disease control
Last updated May 15, 2026 11:57 UTC